Electrogram Width Research Articles

PO-04-138 FINDING THE SIGNAL TO BURN: OPTIMIZED FRACTIONATION MAPPING FOR IDENTIFYING GANGLION PLEXUSES DURING CARDIONEURAL ABLATION

Cardioneural ablation (CNA) is a novel catheter-based technique to treat patients with clinically significant bradyarrhythmia due to cardioinhibitory response in vasovagal syncope (VVS). Three common techniques used to locate areas of ganglion plexuses (GPs) prior to CNA include high frequency stimulation, fractionation mapping (FM), and empiric ablation based on presumed anatomical location of GPs. Optimal intra-procedural diagnostic parameters of fractionation mapping which predict GP location remain ill-defined. To determine the parameters of FM which most precisely locate successful GP ablation sites. Consecutive patients with cardioinhibitory VVS underwent CNA at a single center between March and April 2021. GP sites were targeted with radiofrequency (RF) ablation based on areas demonstrating fractionation, response to high-frequency stimulation, and overall anatomic location. GP sites exhibiting abrupt sinus rate increases with RF delivery were tagged as successful. Following the case, multiple FMs were retrospectively analyzed at 5 sensitivities (range 0.01-0.10 mV), each utilizing 4 combinations of EGMs with width (range 5-10 ms) and refractory interval (range 6-25 ms). Each FM was reviewed and deemed predictive if it identified all successful RF sites without incorrectly annotating sites lacking an RF response. We identified 40 unique FMs for analysis. Setting EGM width to 5 ms and refractory interval to 6 ms predicted all successful ablation sites (positive predictive value [PPV] 100%, p < 0.01). Broadening annotation parameters diminished predictability in a stepwise fashion (5 ms/15 ms, 10 ms/15 ms, 10 ms/25 ms yielded PPV 90%, 70%, 40%, respectively, p < 0.01). Sensitivity settings did not correlate with map utility (PPV 75%, p = 0.98). The optimal fractionation parameters which identified successful ablation sites were those with the narrowest electrogram width and shortest refractory interval. Analysis in a larger cohort is needed to confirm these findings.

Automated isochronal late activation mapping to identify deceleration zones: Rationale and methodology of a practical electroanatomic mapping approach for ventricular tachycardia ablation

Sinus rhythm surrogates for critical isthmus sites are highly desirable because the vast majority of VT is hemodynamically unstable. While many ablation strategies to decrease the arrhythmogenicity of scar have been shown to be effective, the predominant method for electroanatomic mapping relies on a voltage-based depiction of scar and abnormal electrograms. A functional prioritization of slow conduction, distinct from late activation, is feasible in clinical practice with the creation of isochronal late activation maps. Regions of slow conduction are easily visualized with isochronal displays of baseline intrinsic rhythm activation and deceleration zones, where isochrones crowd, have been observed to have strong correlation with successful ablation sites. Automated annotation of the offset of local electrograms was developed to create the propagation maps to incorporate electrogram width and completion of local activation. Simple conduction velocity estimates where three isochrones are seen within a 1 cm radium confirm that deceleration zones harbor conduction velocity of <0.6 m/s. We present a practical methodology of analyzing electroanatomic substrate in a voltage-independent manner with correlation to reentrant VT. Non-linear 3D transmyocardial conduction limits the validity of conduction velocity estimates that assume planar and tangential conduction and we show an example of a patient with 3D isthmus boundaries with an activation gap on the epicardial surface during tachycardia.

Correlation between computer tomography-derived scar topography and critical ablation sites in postinfarction ventricular tachycardia.

Myocardial wall thickness (WT) in patients with a prior myocardial infarction has been used to indicate scarring. However, the correlation of WT with sites critical to ventricular tachycardia (VT) has not been previously investigated. The purpose of this study was to correlate electroanatomic mapping data obtained during VT ablation with WT determined by cardiac computed tomography (CT). Cardiac CTs were performed in 15 consecutive patients (mean age 63 ± 10 years, 86% male, left ventricular ejection fraction 27 ± 12%) with a prior infarct referred for VT ablation. The CTs were registered to the electroanatomic maps obtained during the mapping procedure. Pacing was performed throughout the scar at sites with fractionated electrograms and isolated potentials. Ablation sites were identified by pace-mapping or entrainment-mapping and these sites were correlated with WT. Bipolar and unipolar voltage amplitude and bipolar electrogram width correlated with WT (correlation coefficient: 0.63, 0.65, and 0.41, respectively, P<0.001). Ablation target sites were identified for 58 of 113 inducible VTs. The ablation target sites were located on CT-defined ridges (WT: 4.2 ± 1.2mm) bordered by areas of thinning (WT: 2.6 ± 1.1mm, P<0.0001) in 14 of 15 patients. Ablation targets were found on ridges in 49 of 58 VTs (84%) for which target sites were identified. A total of 70 ridges were localized in the 15 patients. VT became noninducible postablation in 11 of 15 patients (73%). WT measured by CT identifies ridges of myocardial tissue that often are critical for postinfarction VT and that can be appropriate target sites for ablation.

The Use of Signal Analyses of Ventricular Tachycardia Electrograms to Predict the Response of Antitachycardia Pacing in Patients with Implantable Cardioverter‐Defibrillators

Antitachycardia pacing (ATP), a quick, painless, and effective therapy available in implantable cardioverter-defibrillators (ICDs), can terminate most, but not all, sustained ventricular tachycardias (VTs). This study investigated the possible ventricular electrogram (EGM) factors for predicting the effectiveness of ATP therapy from ICD recordings. In this study, we analyzed 113 EGMs of VT episodes acquired from 20 patients who received ATP or shock to terminate tachyarrhythmias during follow-up after ICD implantations. The relationship between the outcome of ATP and VT EGM features (such as voltage, width, cycle length, and beat-to-beat morphologic variation) was investigated. The divergence (beat-to-beat morphologic variation) of the VT EGMs was determined by calculating the total deviation of all EGMs away from the average template after all VT EMGs were aligned. In total, 72 (63.7%) successful (Group I) and 41 (36.3%) unsuccessful (Group II) ATP therapy episodes were analyzed. The mean amplitude, cycle length, and EGM width were similar between these 2 groups (P > 0.05). A multivariate analysis demonstrated that the only predictor of successful ATP was the divergence among the VT EGMs (0.56 ± 0.32 vs 1.07 ± 0.64, P < 0.001, for Groups 1 and 2, respectively). The optimal cutoff value for determining a successful ATP therapy was 0.73 (with an area under the curve of 0.769, sensitivity of 81.9% [95% CI = 71.1-90.0], and specificity of 65.9% [95% CI = 49.4-79.9], P < 0.0001). Signal analyses from stored EGMs of VT can predict the response of ATP therapy in patients with ICD implantations. A lesser ventricular beat-to-beat morphologic variation in the intracardiac recordings from ICDs correlated with a higher probability of a successful ATP.

Catheter‐Tissue Contact Force Determines Atrial Electrogram Characteristics Before and Lesion Efficacy After Antral Pulmonary Vein Isolation in Humans

Electrogram (EGM) characteristics are used to infer catheter-tissue contact. We examined if (a) atrial EGM characteristics predicted CF and (b) compared the value of CF versus other surrogates for predicting lesion efficacy. Twelve paroxysmal AF patients underwent pulmonary vein isolation using radiofrequency (RF) ablation facilitated by a novel CF-sensing catheter. Operators were blinded to CF. EGM amplitude, width, and morphology were measured pre- and post-RF. At each RF site, average CF, force-time integral (FTI), impedance fall, time to impedance plateau, maximum power, catheter tip temperature, and total energy delivered were recorded. An effective lesion was defined based on previously validated EGM criteria for transmural lesions. There was a moderate correlation between CF and EGM amplitude (r = 0.19) and EGM width (r = -0.22). Pre-RF, EGM amplitude, and width had modest to poor discriminative capacity for identifying preablation CF (e.g., EGM amplitude identified CF>20 g with sensitivity and specificity of 67% and 60%, respectively). Preablation CF, FTI, and total energy delivered during RF were the only independent predictors of effective lesion formation. Neither pre-RF EGM amplitude/width nor power, temperature, and impedance changes during RF predicted effective lesion formation. An average CF >16 g or FTI >404 g*s had excellent sensitivity and specificity (>80%) for identifying an effective lesion. EGM characteristics do not reliably predict either CF before the onset of RF, nor do they predict the likelihood of an effective lesion. CF parameters were superior to power, temperature, and impedance changes during RF in predicting lesion efficacy.

Influence of isoproterenol on the accelerated junctional rhythm observed during radiofrequency catheter ablation of atrioventricular nodal slow pathway conduction

Background Accelerated junctional rhythm (AJR) has been considered as a sensitive but rather nonspecific marker of successful radiofrequency (RF) ablation of slow pathway in patients with atrioventricular nodal reentrant tachycardia (AVNRT). However, AJR also occurs commonly during isoproterenol infusion. We therefore investigated the effect of isoproterenol on the significance of AJR while attempting slow pathway ablation. Methods Forty patients with AVNRT underwent slow pathway ablation. Sixty-nine RF applications accompanied by AJR were observed and were separated into 2 groups: applications performed without (group I, n = 26) and with (group II, n = 43) isoproterenol infusion. The specificity of AJR for successful ablation for each group was calculated. Results The specificity of AJR in groups I and II was 73% (19/26) and 49% (21/43), respectively (P <.05). There was no significant difference between the groups in the atrial electrogram width, atrial/ventricular electrogram amplitude ratio, the time from application onset to AJR emergence, or AJR cycle length. The catheter-tip temperature at AJR emergence was significantly lower (47°C ± 3°C vs 52°C ± 3°C, P <.001) and the ratio of junctional beats to total heart beats during RF application was significantly greater (46% ± 24% vs 33% ± 18%, P <.05) in group II compared with group I. Conclusions Isoproterenol lowers the threshold of AJR emergence during RF application and thereby lowers the specificity of AJR for successful ablation. Complete washout of isoproterenol may therefore improve the specificity of AJR during RF ablation in patients with AVNRT. (Am Heart J 2001;142:664-8.)

The potential for inappropriate ventricular tachycardia confirmation using the Intracardiac Electrogram (EGM) Width Criterion.

The "Intracardiac Electrogram (EGM) Width Criterion," the first digital signal processing feature used in an implantable cardioverter defibrillator (ICD), is a detection enhancement algorithm that intends to improve ventricular tachycardia (VT) detection specificity by rejecting inappropriately detected supraventricular tachyarrhythmias. The algorithm may be activated after setting the optimal EGM source, slew, and width thresholds based on EGM width testing during sinus rhythm. This study evaluates the accuracy of the EGM width measurements during exercise testing. Twenty-one patients with Medtronic Micro Jewel II Model 7223 ICDs underwent treadmill exercise testing. EGM width testing was repeatedly performed during exercise and recovery to detect potential inappropriate measurements. In seven (33%) patients the EGM Width Criterion inappropriately confirmed VT detection. Eleven patients had inappropriately wide EGM width measurements, but did not satisfy the EGM Width Criterion. The causes of wide EGM width measurements were an actual increase in EGM width and/or inappropriate detection of the baseline irregularities as EGM onset or offset points. Based on our observations, we recommend to test the EGM Width Criterion during exercise testing for optimal ICD programming.

Arrhythmia Detection Algorithms in Dual Chamber ICDs

In the conventional ICDs, the arrhythmia detection algorithm relies primarily on a analysis of the ventricular rate and stability, and do not adequately differentiate ventricular tachycardia (VT) from supraventricular tachycardia (SVT). Not unexpectedly, the latter arrhythmias may be misclassi~ed and lead to inappropriate ICD therapy in 20–30% of the implanted patients [1,2]. This inappropriate therapy frequently manifests as ICD cluster shocks that are not only painful but may also be, at times, proarrhythmic. The speci~city of the arrhythmia detection may be improved by detection enhancements such as sudden onset, stability, electrogram width or sustained rate duration [3,4]. Their use, however, has not gained widespread acceptance due to con_icting ~ndings regarding their potential ef~cacy and potential concerns regarding underdetection of the clinical VT [5]. The dual chamber ICDs provide a capability for combined detection and analysis of the atrial and ventricular electrograms [6,7]. This makes it possible to design innovative detection algorithms, which may allow for better differentiation of VT from SVT/atrial ~brillation (AF). This chapter will provide a critical appraisal of the clinical utility of arrhythmia detection algorithms in the available dual chamber ICDs.

Effects of Different Atrial Pacing Modes on Atrial Electrophysiology

Multiple-site atrial pacing has been shown to prevent recurrence of atrial fibrillation. However, information about the mechanisms of different atrial pacing modes in prevention of atrial fibrillation was not clear. Forty-two patients without structural heart disease were classified into group 1 and group 2 according to absence or presence of clinical atrial fibrillation, respectively. Atrial conduction time and electrogram width of the right posterior interatrial septum (RPS) were measured during drive-train stimulation (S1) and early extrastimulation (S2). The locations of S1 were the high right atrium (HRA), distal coronary sinus (DCS), or both sites simultaneously. Effective refractory periods (ERPs) of the HRA and DCS were also determined during S1 stimulation at each site and during biatrial pacing. The ERPs were not different between single-site atrial pacing and biatrial pacing. In contrast, early S2 stimulation at the HRA caused greater atrial conduction delay and greater increment of electrogram width of the RPS in patients with a history of atrial fibrillation. Biatrial pacing significantly reduced the conduction delay and electrogram width of the RPS caused by HRA extrastimulation. In addition, in 17 group 2 patients, atrial fibrillation was induced by an early HRA S2 coupled to HRA pacing. However, with the same coupling interval of S2 at HRA, only 6 of them had the arrhythmia induced during biatrial pacing. Furthermore, conduction delay and increase of electrogram width caused by early S2 at the HRA were reduced by biatrial pacing only in patients whose arrhythmia induction was successfully prevented by biatrial pacing. Biatrial pacing reduced both the atrial conduction delay and increase of electrogram width at the RPS caused by early S2 at HRA, and these effects could prevent induction of atrial fibrillation.

Preferential Action of Mexiletine on Central Common Pathway of Reentrant Ventricular Tachycardia

The action of mexiletine on diseased myocardium was assessed in reentrant ventricular tachycardia (VT). Whether class Ib antiarrhythmic agents exert a preferential action on the central common pathway of reentrant ventricular tachycardia has not yet been studied in humans. In 10 consecutive patients (7 with a previous myocardial infarction, 3 with nonischemic disease), VT was induced and entrained with rapid pacing. The orthodromic conduction time was measured from stimulus to the entrained electrogram at the exit from the presumed central common pathway (i.e., the earliest site of activation). Mexiletine at 125 to 250 mg was administered intravenously, and when VT with the same configuration was induced, the study was repeated. The action of mexiletine on the central common pathway was assessed from the changes in VT cycle length and orthodromic conduction time. The effects on QRS complex duration, local conduction time between the exit and the pacing site and duration of the local electrogram were compared between normal and diseased myocardium. Mexiletine prolonged the VT cycle length in all patients, from (mean +/- SD) 316 +/- 30 to 360 +/- 64 ms (mean change 20 +/- 7%, p < 0.001); during entrainment of VT, the orthodromic conduction time was prolonged, from 306 +/- 58 to 367 +/- 89 ms (mean change 18 +/- 9%, p < 0.001). These changes were highly correlated (r = 0.95, p < 0.001). QRS duration changed little (4 +/- 3%), and local conduction time showed no change. The duration of the fragmented electrogram width was prolonged by mexiletine: from 146 +/- 50 to 176 +/- 56 ms (mean change 23 +/- 8% during VT, p < 0.001). Only a slight change occurred in the effective refractory period, both at the pacing site and at the exit. Mexiletine caused little change in conduction time in normal myocardium but prolonged VT cycle length, orthodromic conduction time and duration of the local electrogram at the earliest site of activation of VT. From these findings, a preferential action of mexiletine on diseased myocardium was suggested but seemed to occur only at higher frequencies during tachycardia.

Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation.

Atrial dysrhythmia patients have exaggerated intra-atrial conduction delays and prolonged relative refractoriness in response to atrial premature depolarizations (APDs). Furthermore, atrial fibrillation (AF) is more readily inducible by APDs from the high right atrium (HRA) than the coronary sinus (CS). In this study, we postulated that site-specific intra-atrial conduction delays can explain why AF is initiated more from the HRA than from the CS. We examined 17 patients (age, 49 +/- 22 years) without a history of atrial flutter, AF, or structural heart disease. Programmed stimulation was carried out from the HRA and distal CS, and bipolar recordings were made at the HRA, His bundle, posterior triangle of Koch, and CS. More prolongations in conduction and relative refractoriness in all intra-atrial sites were observed during HRA than CS APDs. AF was induced in 8 patients after HRA and not CS stimulation. During HRA stimulation, patients with AF inducibility exhibited significant prolongation of conduction to the posterior triangle of Koch and marked broadening of the posterior triangle of Koch electrogram compared with CS stimulation. In patients without AF inducibility, the posterior triangle of Koch electrogram width was the same during HRA and CS stimulation. The existence of site-dependent intra-atrial conduction delays and site-dependent dispersion of refractoriness appears to be a common property of the atrial myocardium and does not necessarily forecast AF inducibility. However, the presence of nonuniform anisotropic characteristics of the posterior triangle of Koch may be critical for AF induction.

Intracardiac electrogram width measurement for improved tachycardia discrimination: Initial results of a new implantable cardioverter-defibrillator (ICD)

Intracardiac electrogram width measurement for improved tachycardia discrimination: Initial results of a new implantable cardioverter-defibrillator (ICD)

Repetitive Atrial Firing and Fragmented Atrial Activity Elicited by Extrastimuli in the Sick Sinus Syndrome With and Without Abnormal Atrial Electrograms

Endocardial catheter mapping of the right atrium during sinus rhythm and programmed atrial stimulation were performed in 50 patients with sick sinus syndrome to investigate the relationship between abnormal atrial electrograms recorded during sinus rhythm and some determinants of the atrial vulnerability such as repetitive atrial firing and fragmented atrial activity elicited by single extrastimulus. The patients were divided into 2 groups on the basis of the presence (Group I) or absence (Group II) of abnormal atrial electrograms recorded during sinus rhythm. In Group I (N = 32), repetitive atrial firing was induced in 23 (72%) patients, and in Group II (N = 18) in 6 (33%) patients; p less than 0.01. The repetitive atrial firing zone was 41 +/- 37 ms in Group I and 12 +/- 18 ms in Group II; p less than 0.001. Fragmented atrial activity was induced in 30 (94%) patients from Group I, and in 8 (44%) patients from Group II; p less than 0.0001. The fragmented atrial activity zone was 47 +/- 42 ms in Group I and 14 +/- 19 ms in Group II; p less than 0.0001. The atrial electrogram width at the premature beat (A2; p < 0.02) and the maximum A2/A1 ratio (p < 0.002) were 178 +/- 53 ms and 196% +/- 40%, respectively in Group I, and 141 +/- 36 ms and 159% +/- 30%, respectively in Group II. Atrial fibrillation was induced in 13 (41%) patients from Group I, and in 1 (6%) patient from Group II (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)